5T4-targeted Immunotherapy Promising in Metastatic Colorectal Cancer 5T4-targeted Immunotherapy Promising in Metastatic Colorectal Cancer

Immunotherapy with modified vaccinia Ankara-5T4 (MVA-5T4, TroVax) may improve survival in patients with metastatic colorectal cancer, researchers report.Reuters Health Information

Source: Medscape Medical News Headlines - September 18, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news